跳至主要内容
临床试验/IRCT20220610055126N1
IRCT20220610055126N1招募中3 期

Comparing the pain control effect of liquid phase concentrated growth factors with Lidocaine 2%, masseter and temporalis muscle trigger points and pain free mouth opening in patients with myofascial pain syndrome

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 80 years(—)
性别
All

入选标准

  • Age between 15 and 80 years [=15 and =80]
  • Presence of at least one trigger point in the masseter or temporalis muscle, previously detected
  • Patient’s agreement for participation in this study.
  • Presence of myofascial pain within masseter muscles according to the RDC/TMD (Ia and Ib)

排除标准

  • Patients being treated or addicted to painkillers and / or drugs that affect muscle function. Such as: muscle relaxants, anti-inflammatory, benzodiazepines
  • Patients with mental disorders
  • Patients with neuropathic pain and neurological disorders (trigeminal neuralgia)
  • Patients with headache
  • Edentulous patients
  • Patients after radiotherapy
  • Pregnancy or lactation
  • Pain of dental origin
  • Drug and/or alcohol addiction
  • Patients with needle phobia
  • Patients with bleeding disorders
  • Metabolic (diabetes) and vascular diseases

研究者

相似试验